Spectrum Science, a Washington, DC-based integrated marketing, communications and media firm focused on science, received an investment from Knox Lane.
The amount of the deal was not disclosed.
The company intends to use the funds for continued expansion of its strategic communications capabilities, while also building on its approach to clinical trial recruitment, broaden consultative capabilities for medical affairs clients and drive enhanced tech enablement throughout the organization.
Owned by industry veteran Jonathan Wilson, Spectrum Science is an integrated marketing, communications and media firm for the pharmaceutical, biotech and broader life science industries with end-to-end capabilities, and a team experts in healthcare and science to focus on strategic engagements with audiences. The company leverages human-centered insights, motivating creative, innovative storytelling and technology to reach audiences across the healthcare sector.
Today, Spectrum employs more than 300 individuals across the U.S. and UK.
FinSMEs
08/02/2023